1. Management of Chronic Hepatitis B in Children

   • Danielle Wendel
   • Karen F. Murray

   Hepatitis B (J Lim, Section Editor) 02 May 2017 Pages: 81 - 89

2. Clinical Implications and Management of Chronic Occult Hepatitis B Virus Infection

   • Mohit Mittal
   • Ke-Qin Hu

   Hepatitis B (J Lim, Section Editor) 17 May 2017 Pages: 90 - 96

3. Impact of Non-alcoholic Fatty Liver Disease on Chronic Hepatitis B Infection

   • Anthony W.H. Chan
   • Grace L.H. Wong
   • Vincent W.S. Wong

   Hepatitis B (J Lim, Section Editor) 27 April 2017 Pages: 97 - 104

4. Ethnic Disparities in Chronic Hepatitis B Infection: African Americans and Hispanic Americans

   • Kimberly A. Forde

   Hepatitis B (J Lim, Section Editor) 22 May 2017 Pages: 105 - 112

5. Autoimmune Hepatitis: When Is It Safe to Stop Therapy, or Withhold Therapy Altogether?

   • Christina Weiler-Normann
   • Johannes Hartl
   • Ansgar W. Lohse

   Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors) 08 May 2017 Pages: 113 - 118

6. Why Doesn’t Primary Biliary Cholangitis Respond to Immunosuppressive Medications?

   • Antonio Molinaro
   • Hanns-Ulrich Marschall

   Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors) Open access 27 April 2017 Pages: 119 - 123

7. Are Dominant Strictures in Primary Sclerosing Cholangitis a Risk Factor for Cholangiocarcinoma?

   • Roger W Chapman
   • Kate D. Williamson

   Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors) Open access 27 April 2017 Pages: 124 - 129

   

8. The Causes and Clinical Spectrum of Drug-Induced Cholestatic Liver Injury

   • Lara Dakhoul
   • Raj Vuppalanchi

   Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors) 12 May 2017 Pages: 130 - 136

9. Should AFP (or Any Biomarkers) Be Used for HCC Surveillance?

   • Hager F. Ahmed Mohammed
   • Lewis R. Roberts

   Hepatic Cancer (A Singal and A Mufti, Section Editors) 28 April 2017 Pages: 137 - 145

   

10. Multidisciplinary Team Management of Patients with Hepatocellular Carcinoma

    • Caitlin A. Hester
    • Ali A. Mokdad
    • Adam C. Yopp

    Hepatic Cancer (A Singal and A Mufti, Section Editors) 05 May 2017 Pages: 146 - 151

    

11. Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?

    • Hannes Hagström

    Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors) Open access 22 April 2017 Pages: 152 - 157

12. Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation

    • Andrea Mancuso

    Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors) 22 April 2017 Pages: 158 - 163

13. Biomarkers and Liver Disease: Can We Predict Decompensation with suPAR?

    • Alexander Koch
    • Frank Tacke

    Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors) 27 April 2017 Pages: 164 - 168